5:35 PM
 | 
Dec 07, 2012
 |  BC Extra  |  Financial News

AcelRx raises $41.4 million in follow-on

AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) raised $41.4 million through the sale of 12.5 million shares at $3.31 in a bumped-up follow-on underwritten by Jefferies; Cowen; and Canaccord. On...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >